| Ilene Katz Weizer, MD | |
|
700 Schuylkill Manor Rd Ste 206, Pottsville, PA 17901 | |
| (570) 628-4200 | |
| (570) 628-4824 |
| Full Name | Ilene Katz Weizer |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 700 Schuylkill Manor Rd Ste 206, Pottsville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093713166 | NPI | - | NPPES |
| 0014618530004 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD047488L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| Lehigh Valley Hospital - Hazleton | Hazleton, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schuylkill Health System Medical Group, Inc. | 0840285532 | 87 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2's spike protein receptor-binding domain (S-RBD) using computationally validated peptide beacons in a single-step detection through the production of a fluorescence signal.
The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.
› Verified 3 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2's spike protein receptor-binding domain (S-RBD) using computationally validated peptide beacons in a single-step detection through the production of a fluorescence signal.
The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ilene Katz Weizer, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Ilene Katz Weizer, MD 700 Schuylkill Manor Rd Ste 206, Pottsville, PA 17901 Ph: (570) 628-4200 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2's spike protein receptor-binding domain (S-RBD) using computationally validated peptide beacons in a single-step detection through the production of a fluorescence signal.
The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.
› Verified 3 days ago
Dr. David Paul Krewson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Red Horse Rd, Pottsville, PA 17901 Phone: 570-628-2229 Fax: 570-628-5185 | |
Dr. Joseph L Russino, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 700 E Norwegian St, Pottsville, PA 17901 Phone: 570-621-4000 | |
Dr. Robert Miles Zimmerman Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Red Horse Rd, Pottsville, PA 17901 Phone: 570-628-2229 Fax: 570-628-5185 | |
James C Xenophon, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Red Horse Rd, Pottsville, PA 17901 Phone: 570-628-2229 Fax: 570-516-9212 | |
Jangwoo Lee, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 101 W Market And Center St, Thompson Bldg, Ste 311, Pottsville, PA 17901 Phone: 570-628-5625 Fax: 570-628-0393 | |
Ashley Costa, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 171 Red Horse Rd, Pottsville, PA 17901 Phone: 570-628-2229 Fax: 570-628-5182 |